Back to search

Article

Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2A

2023-04-26

Abstract excerpt

<title>Abstract</title> <p>Mitofusin-2 (MFN2) is an outer mitochondrial membrane protein essential for mitochondrial networking in most cells. Autosomal dominant mutations in the <italic>MFN2 </italic>gene cause Charcot-Marie-Tooth type 2A disease (CMT2A), a severe and disabling sensory-motor neuropathy that impacts the entire nervous system. Here, we propose a novel therapeutic strategy tailored to correcting th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4242390c-2c54-5294-a28c-e914dfc24bed
DOI
10.21203/rs.3.rs-2817290/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2ADOI 10.21203/rs.3.rs-2817290/v1
Select a neighboring publication to make it the new centre.